SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-027375
Filing Date
2020-09-18
Accepted
2020-09-18 16:36:25
Documents
1
Period of Report
2020-09-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3893
  Complete submission text file 0001213900-20-027375.txt   5532
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8767 E. VIA DE VENTURA, SUITE 190 SCOTTSDALE AZ 85258
Business Address
ZELDIS JEROME B (Reporting) CIK: 0001433982 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14778 | Film No.: 201184363